Quality Of Life In Colorectal Cancer Survivors
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Quality of Life Assessment.
- Who it may be relevant to
- Registry conditions: Colorectal Cancer, Colon Cancer, Rectal Cancer. Basic parameters: from 18 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Slovenia
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Overview
The purpose of this study is to identify late adverse effects in colorectal cancer patients that may influence quality of life at 6, 12, and 24 months after oncological treatment. The study aims to assess quality of life in colorectal cancer survivors in relation to psycho-physical-social well-being at different time points and to evaluate the prevalence of late adverse effects and their association with diagnosis and specific oncological treatment.
Detailed description
The purpose of this study is to identify late adverse effects in patients with colorectal cancer that may influence quality of life at 6, 12, and 24 months after oncological treatment. The study will assess quality of life in colorectal cancer patients in relation to psycho-physical-social well-being at different time points. In addition, the study will identify and evaluate the prevalence of late adverse effects and analyze their association with diagnosis and specific oncological treatment.
Interventions
- Other Quality of Life Assessment
Quality of life assessment using questionnaires at 6, 12, and 24 months after oncological treatment.
Primary outcome measures
- Quality of Life Score (EORTC QLQ-C30 Global Health Status/QoL Scale) [Time frame: 6, 12, and 24 months after oncological treatment]
Secondary outcome measures (1)
- Colorectal Cancer-Specific Quality of Life (EORTC QLQ-CR29) [Time frame: 6, 12, and 24 months after oncological treatment]
Eligibility criteria
Inclusion criteria
- Patients with colorectal cancer (colon or rectal cancer)
- Age 25 to 65 years
- First oncological treatment performed at the Institute of Oncology Ljubljana
- Working-capable patients
- Ability to complete questionnaires
- Ability to provide written informed consent
Exclusion criteria
- Age < 25 years or > 65 years
- Patients unable to complete questionnaires
- Patients unable to participate in follow-up assessments
- Patients who do not provide written informed consent
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Allocation
- N/A
- Model
- Single group
- Masking
- Open label
- Primary purpose
- Other
Study locations
Slovenia · 1 center
- Institute of Oncology Ljubljana — Ljubljana
Identifiers
NCT: NCT07427901 · OIL_CCS_2023 · ERIDNPVO-0051/2023 · 0120-192/2023/6